JP2020502228A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502228A5
JP2020502228A5 JP2019534154A JP2019534154A JP2020502228A5 JP 2020502228 A5 JP2020502228 A5 JP 2020502228A5 JP 2019534154 A JP2019534154 A JP 2019534154A JP 2019534154 A JP2019534154 A JP 2019534154A JP 2020502228 A5 JP2020502228 A5 JP 2020502228A5
Authority
JP
Japan
Prior art keywords
compound
solvent
formula
reaction mixture
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019534154A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020502228A (ja
JP7294661B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2017/058374 external-priority patent/WO2018116281A1/en
Publication of JP2020502228A publication Critical patent/JP2020502228A/ja
Publication of JP2020502228A5 publication Critical patent/JP2020502228A5/ja
Priority to JP2023016009A priority Critical patent/JP2023052918A/ja
Application granted granted Critical
Publication of JP7294661B2 publication Critical patent/JP7294661B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019534154A 2016-12-23 2017-12-22 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス Active JP7294661B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023016009A JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382648 2016-12-23
EP16382648.0 2016-12-23
PCT/IB2017/058374 WO2018116281A1 (en) 2016-12-23 2017-12-22 Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023016009A Division JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Publications (3)

Publication Number Publication Date
JP2020502228A JP2020502228A (ja) 2020-01-23
JP2020502228A5 true JP2020502228A5 (https=) 2021-02-12
JP7294661B2 JP7294661B2 (ja) 2023-06-20

Family

ID=57799523

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019534154A Active JP7294661B2 (ja) 2016-12-23 2017-12-22 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス
JP2023016009A Withdrawn JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023016009A Withdrawn JP2023052918A (ja) 2016-12-23 2023-02-06 5-[[4-[2-[5-(1-ヒドロキシエチル)-2-ピリジニル]エトキシ]フェニル]メチル]-2,4-チアゾリジンジオンおよびその塩を調製するためのプロセス

Country Status (19)

Country Link
US (2) US11124505B2 (https=)
EP (1) EP3559010B1 (https=)
JP (2) JP7294661B2 (https=)
KR (1) KR102609373B1 (https=)
CN (1) CN110198945B (https=)
BR (1) BR112019012972B1 (https=)
CA (1) CA3046744A1 (https=)
CY (1) CY1125531T1 (https=)
DK (1) DK3559010T3 (https=)
ES (1) ES2926580T3 (https=)
HR (1) HRP20221067T1 (https=)
HU (1) HUE059604T2 (https=)
IL (1) IL267557B (https=)
LT (1) LT3559010T (https=)
MX (1) MX379709B (https=)
PL (1) PL3559010T3 (https=)
PT (1) PT3559010T (https=)
SI (1) SI3559010T1 (https=)
WO (1) WO2018116281A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2926580T3 (es) 2016-12-23 2022-10-27 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma
CN112823004A (zh) 2018-06-06 2021-05-18 米尼奥尔克斯治疗有限公司 5-[[4-[2-[5-乙酰基吡啶-2-基]乙氧基]苄基]-1,3-噻唑烷-2,4-二酮及其盐的用途
EP3801515B1 (en) 2018-06-06 2025-04-09 Minoryx Therapeutics S.L. 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases
CN112512524A (zh) 2018-06-06 2021-03-16 米尼奥尔克斯治疗有限公司 给予治疗有效量的5-[[4-[2-[5-(1-羟基乙基)吡啶-2-基]乙氧基]苯基]甲基]-1,3-噻唑烷-2,4-二酮的方法
EP4642456A1 (en) 2022-12-28 2025-11-05 Minoryx Therapeutics S.L. Optimized dosing of leriglitazone
WO2024231881A2 (en) 2023-05-09 2024-11-14 Minoryx Therapeutics S.L. Polymorphic forms and formulations of leriglitazone

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231886T2 (de) * 1991-04-11 2002-03-28 Pharmacia & Upjohn Co., Kalamazoo Thiazolidindionderivate, herstellung und anwendung
US5952509A (en) 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
US6067749A (en) 1996-07-11 2000-05-30 Tasmanian Alkaloids Pty. Ltd. Papaver somniferum strain with high concentration of thebaine and oripavine
US5869669A (en) 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
HUP0304096A2 (hu) 2003-12-19 2005-08-29 Richter Gedeon Vegyészeti Gyár Rt. Eljárás pioglitazon hidrogénklorid előállítására és intermedierjei
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2594666A1 (en) 2005-02-16 2006-08-24 Micromet Ag Use of activated polymers for separation of protein and polypeptide multimers
US20090247560A1 (en) * 2006-09-28 2009-10-01 Banyu Pharmaceutical Co., Ltd. Diaryl ketimine derivative
JPWO2008136428A1 (ja) * 2007-04-27 2010-07-29 武田薬品工業株式会社 含窒素5員複素環化合物
EP2855489B1 (en) * 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
WO2014152843A1 (en) 2013-03-14 2014-09-25 Deuterx, Llc Deuterium-enriched 2,4-thiazolidinediones and methods of treatment
EA202091120A3 (ru) 2014-04-02 2020-12-30 Минорикс Терапьютикс С.Л. Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы
ES2926580T3 (es) 2016-12-23 2022-10-27 Minoryx Therapeutics S L Proceso para preparar 5-[[4-[2-[5-(1-hidroxietil)-2-piridinil]etoxi]fenil]metil]-2,4-tiazolidindiona y sales de la misma

Similar Documents

Publication Publication Date Title
JP2020502228A5 (https=)
CN101778852B (zh) 双胺化锌碱
JP3501008B2 (ja) 含硫黄有機珪素化合物の製造方法およびその合成中間体の製造方法
KR101485879B1 (ko) 에스테르 작용성 실란의 제조 방법
HRP20221067T1 (hr) Postupak priprave 5-[[4-[2-[5-(1-hidroksietil)-2-piridinil]etoksi]fenil]metil]-2,4-tiazolidindiona i njegovih soli
CN107004906B (zh) 含镁电解液
JP3728236B2 (ja) テトラキスフルオロアルキルホウ酸塩およびそれらの導電性塩としての使用
CN101044138A (zh) 吲唑化合物的制备方法
EP3546443B1 (en) Method for producing fluorine-containing dialkyl carbonate compounds
US11180469B2 (en) Method for preparing sultone derivatives
KR102688867B1 (ko) 리튬 이미다졸레이트염의 제조방법 및 그를 위한 중간체
KR20130114574A (ko) 하이드록시 말단을 지니는 오가노실리콘 글리콜-기반 전해질
CN1918168B (zh) 制备3-o-保护吗啡酮和3-o-保护吗啡酮二烯醇羧酸酯的方法
JP2008303161A (ja) 含フッ素アルコキシアルカンの製造方法
JP3366290B2 (ja) 置換ピペリジンエポキシドの製造方法
JP5095945B2 (ja) 4−トリフルオロメチルニコチン酸又はその塩の製造方法
JP7545079B2 (ja) フルオロポリエーテル基含有化合物
JP2009084193A (ja) チアゾリウム塩
JP7738290B2 (ja) ゴム組成物の製造方法
US7087755B1 (en) Substituted pyridines
IL149063A (en) Process for the preparation of ariltriazolanones and their new intermediates
CN106939012B (zh) 一种奈他地尔中间体的制备方法
EP3521293A1 (en) Process for the preparation of an inhibitor of phosphodiesterase 4
JP7517244B2 (ja) ヒドロキシアルキルシラン化合物の製造方法
JP2016040233A (ja) ビシクロアミノオルガノキシシラン化合物及びその製造方法